Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200037/S021

ASSURE Wearable Cardioverter Defibrillator (WCD) System

Kestra Medical Technologies, Inc. · Decision date Sep 28, 2026

MEDTECHLEDGER EXPLANATIONP200037/S021

What did the FDA decide?

The FDA record for P200037/S021 identifies a 30-day notice for the ASSURE Wearable Cardioverter Defibrillator (WCD) System, product code MVK, submitted by Kestra Medical Technologies, Inc. The stated purpose is an updated workflow for the post-wear data transfer process, filed under the supplement reason process change affecting a manufacturer, sterilizer, packager or supplier.

The S021 suffix ties this filing to the original PMA P200037, but it is a supplement, not a new approval of the whole system. The notice describes a manufacturing and process update only; it does not establish safety or clinical effectiveness. The record does not specify which workflow steps, data pathways or components changed, leaving that detail absent.

FDA approval order statement

an updated workflow for the post-wear data transfer process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200037/S021
Regulatory pathway
PMA supplement
Product code
MVK
Decision code
OK30
Decision date
Sep 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wearable automated external defibrillator.

Product code
MVK
FDA device class
3

For the original device and its historical approval scope, see PMA P200037. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200037 · Original PMA

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  2. P200037/S021 received

    Application receipt date recorded by FDA.

  3. P200037/S021 · FDA decision

    30-Day Notice

  4. P200037/S022 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

Timeline entries are records held by MedtechLedger for P200037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200037

Product / regulatory recordCompanyPathwayDecision dateSource
Kestra Medical Technologies, Inc.PMA approvalJul 27, 2021FDA
Kestra Medical Technologies, Inc.PMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code MVK

Product / regulatory recordCompanyPathwayDecision dateSource
Zoll Manufacturing CorporationPMA supplementOct 6, 2026FDA
Zoll Manufacturing CorporationPMA supplementOct 5, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 29, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 9, 2026FDA
Zoll Manufacturing CorporationPMA approvalDec 18, 2001FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kestra Medical Technologies, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3933 Lake Washington Blvd. NE, Suite 200, Kirkland, WA, 98033

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records